means that only 13 percent of the world's population will initially have access to the drugs mark slawson the head of oxfam's inequality policy division sees pharmaceutical companies are seeking to maximize profits it's extremely dangerous for the world because a rich nations are monopolizing the supply of a potential. but more importantly they're doing deals with big pharmaceutical corporations which are defending their intellectual property and their profits meaning that the supply of vaccines and being artificially limited. oxfam also say is there will be another vaccine doses to meet global them and the 5 leading vaccine candidates are currently under. going stage 3 clinical trials however even if all 5 proved to be a success which according to the charity is extremely unlikely around 2 thirds of the world's population will still have to wait until 2022 at least on top of potential drug shortages oxfam sees quote the vaccine deals lay bare the inequality between prosperous developing countries. well to give an example the u.k. has managed to secure up to 5 doses per person depending o

only 13 percent of the world's population will initially have access to the sought after drug by slawson the head of oxfam's inequality policy division says this is a consequence of pharmaceutical companies seeking to maximize profits it's extremely dangerous for the world because rich nations monopolizing the supply of a potential banksy but more importantly they're doing deals with big corporations which are defending their intellectual property and their profits meaning that the supply of vaccines being own to fish should be limited. oxfam says there won't be enough vaccines to go around to meet the global demand the 5 leading vaccine candidates for which nations across the world sealed the deal are currently undergoing the final stage of clinical trials however even if all 5 proved to be a success which according to the charity is extremely unlikely around 2 thirds of the world's population will still have to wait at least until 2022 on top of potential drug shortages oxfam says the vaccine deals laid bare the inequality between prosperous and developing countries. for example the u.

in a case that's shocked slawson julie's county of all places in california a place is not often shocked to local law enforcement officers are in critical condition after being targeted by government on saturday and what authorities have described as a cowardly ambush check this surveillance video of them the shooting can be seen walking up to a patrol car and opening fire to county sheriff's deputies one male the other female were inside the vehicle both suffered multiple gunshot wounds a manhunt underway for the suspect with a $10000.00 reward being offered then on saturday night a crowd showed up outside the hospital where those deputies were being treated. oh . cording to the l.a. county sheriff's office protesters blocked emergency exits and were heard shouting derogatory terms about law enforcement 2 people were arrested there with the crowd later dispersed by police because then there's the bigger picture that we've often been talking about here on this channel the incident follows months ago and rest of a police brutality across the u.s. conservative talk radio host dave perkins

contrast that to bangladesh for instance stark contrast the figures only one dose per 9 people might slawson again says that prolonged and availability of the vaccine in some countries is ultimately going to mean many unnecessary deaths. but he's like madonna in the us are only selling their backs into very rich countries they're selling it at a very high price somewhere between $16.00 and $35.00 a dose and you have to have 2 doses so that's like $70.00 per person so they are berry clear that they they're doing this to make a profit and they want to make money from this maxine what we're saying is we need a people's backs not a profit backs a real need to see. the breaking down of the patent barriers and we need to see open sharing your banks in technology to maximize the supply of safe and effective vaccines all over the world as soon as possible the huge economic and human cost of the delay in the variability of the vaccine if you think of countries like india or south africa brazil if these countries are not getting access to safe and effective saying until 2022 then they would have more